Purchase Order 75N93020P01055

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Geneuniversal Inc. valued at $148,279.20 on July 9, 2018, for gene synthesis services. Work is performed in Newark, Delaware. The order is firm fixed price with no set-aside category. Performance was scheduled to conclude by July 8, 2019, and the award was funded through de-obligation of expiring fiscal year 2018 funds.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for $17,209.00 on September 18, 2023, for custom gene synthesis and expression services. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no small business set-aside. The ultimate completion date is December 31, 2023.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. on August 23, 2023, for DNA services valued at $34,502.16. The order covers gene synthesis, VectorArk cloning, and express plasmid preparation. Performance occurs in Piscataway, New Jersey. The services support development of peptide and protein immunogens and DNA constructs for MPER-scaffolded proteins used in vaccine research against HIV, influenza, Ebola, Marburg, and other infectious...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for $14,756.36 on September 13, 2021, for sequencing services under the FY26 UDO Initiative. Performance is at Genscript's facility in Piscataway, New Jersey. The order carries a firm fixed price and was completed by December 31, 2021.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for customized DNA and monoclonal antibody production, valued at $49,653.58, on August 6, 2020. Performance is located in Piscataway, New Jersey. The order is firm fixed price with an ultimate completion date of September 5, 2020.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Gene By Gene, LIMITED for SNP arrays valued at $16,268.00 on September 25, 2020. Performance is located in Houston, Texas, with an ultimate completion date of December 1, 2020. The order uses firm fixed pricing and was awarded without a set-aside designation. The originating solicitation was posted September 10, 2020, with a due date of September 20, 2020.</p>

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $249,996 firm fixed price purchase order to Gene By Gene, LTD for clinical grade whole genome sequencing services. The contract calls for Gene By Gene to deliver these sequencing services from its Houston, Texas facility between September 1, 2023 and December 31, 2023 to support NIAID's research efforts in the areas of allergy and infectious disease. No...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Psomagen Inc. for $10,320.00 on September 15, 2022, for RNA extraction, DNA isolation, and library preparation services under the FY26 UDO Initiative. Work is performed in Rockville, Maryland. The order is firm fixed price with an ultimate completion date of October 14, 2022.</p>

This is a $200,219.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Geneuniversal Inc., a for-profit biotechnology services provider based in Newark, Delaware. The contract is for DNA services including antibody gene synthesis, subcloning, and plasmid preparation to support the Vaccine Research Center's (VRC) efforts to develop vaccines against HIV/AIDS. This is a follow-on requirement to...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for biomaterial on August 11, 2015, with a ceiling value of $34,000.00. Performance takes place in Grand Island, New York. The order is firm fixed price with an ultimate completion date of September 30, 2016.</p>